Eldec Pharmaceuticals
Dr. Saira Ahmad is the Director of Research at Eldec Pharmaceuticals. She received her Ph.D. in Biosciences with a concentration in Microbiology and Infectious Diseases from George Mason University. During this time, she identified a peptide’s mechanism of action for anti-biofilm activity. She also received a fellowship from the National Science Foundation to fund this research. Dr. Ahmad completed her postdoctoral research at the University of North Carolina at Chapel Hill and received a T32 Fellowship through the National Institute of Health to screen peptides for anti-microbial activity and anti-inflammatory effects against CF-related pathogenic infections. Using her extensive background in peptides, microbiology and host–pathogen interactions, Dr. Ahmad leads the scientific research at Eldec Pharmaceuticals.
W32.4- ELD607, an Orai1 antagonist, reverses goblet cell metaplasia in βENaC mice.
Saturday, September 28, 2024
7:45 AM – 9:45 AM ET